First drug candidate will target root causes of debilitating neurological disorders SAN JOSE, Calif., March 8, 2023 /PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company that uses proprietary chemoproteomics technology to discover and develop small molecules for high-value,...
News Ticker
- [ March 25, 2023 ] 89bio to net $275M from stock offering; Assembly Bio to pause work on one HBV inhibitor program News
- [ March 25, 2023 ] Q&A: BioCina’s new CEO Mark Womack on the CDMO he says is ‘worth traveling over’ News
- [ March 25, 2023 ] SLAC’s Sadasivan Shankar on sustainable computing News
- [ March 24, 2023 ] Scientist – Radiant Systems Inc – South San Francisco, CA San Francisco Biotech Jobs
- [ March 24, 2023 ] SENIOR RESEARCH ASSOCIATE/ASSOCIATE SCIENTIST* – CARGO-Therapeutics – San Francisco, CA San Francisco Biotech Jobs
Copyright © 2022 Biotech Networks, LLC
